---
layout: post
title: "Statement of Organization, Functions, and Delegations of Authority"
date: 2026-02-05 18:53:18 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2024-01613
original_published: 2024-01-29 00:00:00 +0000
significance: 8.00
---

# Statement of Organization, Functions, and Delegations of Authority

**Published:** February 05, 2026 18:53 UTC
**Source:** Federal Register
**Original Published:** January 29, 2024 00:00 UTC
**Document Number:** 2024-01613

## Summary

The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality (OPQ) has modified its organizational structure. This new structure was approved by the Secretary of Health and Human Services on August 10, 2023.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2024/01/29/2024-01613/statement-of-organization-functions-and-delegations-of-authority)
- API: https://www.federalregister.gov/api/v1/documents/2024-01613

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
